{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:36Z","timestamp":1792801476063,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["PDF\/2017\/000984"],"award-info":[{"award-number":["PDF\/2017\/000984"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2016-0624\/CMB\/Adhoc-BMS"],"award-info":[{"award-number":["2016-0624\/CMB\/Adhoc-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10787-020-00764-w","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T13:02:43Z","timestamp":1602680563000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Neuroinflammatory responses in Parkinson\u2019s disease: relevance of Ibuprofen in therapeutics"],"prefix":"10.1007","volume":"29","author":[{"given":"Ashish","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6195-9029","authenticated-orcid":false,"given":"Sarika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"issue":"3","key":"764_CR1","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1006\/bbrc.1995.1441","volume":"208","author":"EE Aeberhard","year":"1995","unstructured":"Aeberhard EE, Henderson SA, Arabolos NS, Griscavage JM, Castro FE, Barrett CT, Ignarro LJ (1995) Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 208(3):1053\u20131059. https:\/\/doi.org\/10.1006\/bbrc.1995.1441","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"764_CR2","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/ph3061949","volume":"3","author":"MA Ajmone-Cat","year":"2010","unstructured":"Ajmone-Cat MA, Bernardo A, Greco A, Minghetti L (2010) Non-steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions. Pharmaceuticals (Basel) 3(6):1949\u20131965","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"764_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3923\/jms.2010.49.58","volume":"10","author":"MS Ardestani","year":"2010","unstructured":"Ardestani MS (2010) Parkinson's disease, the inflammatory pathway and anti-inflammatory drug: an overview. J Med Sci 10(3):49\u201358","journal-title":"J Med Sci"},{"issue":"2","key":"764_CR5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2007.05.006","volume":"206","author":"M Asanuma","year":"2007","unstructured":"Asanuma M, Miyazaki I (2007) Common anti-inflammatory drugs are potentially therapeutic for Parkinson\u2019s disease? Exp Neurol 206(2):172\u2013178","journal-title":"Exp Neurol"},{"key":"764_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/157015910790909485","volume":"8","author":"AL Bartels","year":"2010","unstructured":"Bartels AL, Leenders KL (2010) Cyclooxygenase and neuroinflammation in Parkinson\u2019s disease neurodegeneration. Curr Neuropharmacol 8:62\u201368","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"764_CR7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HDE Booth","year":"2017","unstructured":"Booth HDE, Hirst WD, Wade-Martins R (2017) The role of astrocyte dysfunction in Parkinson's disease pathogenesis. Trends Neurosci 40(6):358\u2013370","journal-title":"Trends Neurosci"},{"issue":"Pt 6","key":"764_CR8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST0341341","volume":"34","author":"R Bordet","year":"2006","unstructured":"Bordet R, Ouk T, Petrault O, Gel\u00e9 P, Gautier S, Laprais M, Deplanque D, Duriez P, Staels B, Fruchart JC, Bastide M (2006) PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. BiochemSoc Trans 34(Pt 6):1341\u20131346","journal-title":"BiochemSoc Trans"},{"issue":"3","key":"764_CR9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","volume":"2","author":"J Bov\u00e9","year":"2005","unstructured":"Bov\u00e9 J, Prou D, Perier C, Przedborski S (2005) Toxin-induced models of Parkinson's disease. NeuroRx 2(3):484\u2013494","journal-title":"NeuroRx"},{"key":"764_CR10","first-page":"193","volume":"6","author":"D Bozyczko-Coyne","year":"2007","unstructured":"Bozyczko-Coyne D, Williams M (2007) Therapeutic areas I: central nervous system, pain, metabolic syndrome, urology, gastrointestinal and cardiovascular. Comprehen Med Chem 6:193\u2013228","journal-title":"Comprehen Med Chem"},{"key":"764_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.nbd.2015.03.003","volume":"85","author":"D Br\u00fcck","year":"2016","unstructured":"Br\u00fcck D, Wenning GK, Stefanova N, Fellner L (2016) Glia and alpha-synuclein in neurodegeneration: a complex interaction. Neurobiol Dis 85:262\u2013274","journal-title":"Neurobiol Dis"},{"issue":"3","key":"764_CR12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5001\/omj.2010.49","volume":"25","author":"R Bushra","year":"2010","unstructured":"Bushra R, Aslam N (2010) An overview of clinical pharmacology of Ibuprofen. Oman Med J 25(3):155\u20131661","journal-title":"Oman Med J"},{"issue":"10","key":"764_CR13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrn2214","volume":"8","author":"V Calabrese","year":"2007","unstructured":"Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8(10):766\u2013775","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"764_CR14","first-page":"17","volume":"2","author":"KM Carvalho","year":"2015","unstructured":"Carvalho KM, Winter E, Antunes AMDS (2015) Evaluation of development of R&D into Parkinson\u2019s disease through technology monitoring using patent documents and scientific articles. Intern J Res Pharm Biosci 2(3):17\u201324","journal-title":"Intern J Res Pharm Biosci"},{"key":"764_CR15","first-page":"201","volume":"289","author":"D Casper","year":"2000","unstructured":"Casper D, Yaparpalvi U, Rempel N, Werner P (2000) Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro. NeurosciLett 289:201\u2013204","journal-title":"NeurosciLett"},{"key":"764_CR16","first-page":"308654","volume":"14","author":"Y Chao","year":"2014","unstructured":"Chao Y, Wong SC, Tan EK (2014) Evidence of inflammatory system involvement in Parkinson\u2019s disease. Biomed Res Int 14:308654","journal-title":"Biomed Res Int"},{"issue":"2","key":"764_CR17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1471-4159.2008.05388.x","volume":"106","author":"RK Chaturvedi","year":"2008","unstructured":"Chaturvedi RK, Beal MF (2008) PPAR: a therapeutic target in Parkinson\u2019s disease. J Neurochem 106(2):506\u2013518","journal-title":"J Neurochem"},{"key":"764_CR18","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","volume":"60","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM (2003) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 60:1059\u20131064","journal-title":"Arch Neurol"},{"key":"764_CR19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","volume":"58","author":"H Chen","year":"2005","unstructured":"Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A (2005) Nonsteroidal anti-inflammatory drug use and the risk for Parkinson's disease. Ann Neurol 58:963\u2013967","journal-title":"Ann Neurol"},{"issue":"4","key":"764_CR20","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"WW Chen","year":"2016","unstructured":"Chen WW, Zhang X, Huang WJ (2016) Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep 13(4):3391\u20133396","journal-title":"Mol Med Rep"},{"issue":"6","key":"764_CR21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1476-5381.2009.00022.x","volume":"156","author":"Y Choi","year":"2009","unstructured":"Choi Y, Lee MK, Lim SY, Sung SH, Kim YC (2009) Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells. Br J Pharmacol 156(6):933\u2013940","journal-title":"Br J Pharmacol"},{"key":"764_CR22","first-page":"183","volume":"149","author":"V Colafrancesco","year":"2011","unstructured":"Colafrancesco V, Villoslada P (2011) Targeting NGF-pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases. Arch Biol 149:183\u2013192","journal-title":"Arch Biol"},{"issue":"4","key":"764_CR23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/157015912804499465","volume":"10","author":"A Contestabile","year":"2012","unstructured":"Contestabile A, Monti B, Polazzi E (2012) Neuronal-glial interactions define the role of nitric oxide in neural functional processes. Curr Neuropharmacol 10(4):303\u2013310","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"764_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12974-018-1305-3","volume":"15","author":"C Corwin","year":"2018","unstructured":"Corwin C, Nikolopoulou A, Pan AL, Nunez-Santos M, Vallabhajosula S, Serrano P, Figueiredo-Pereira ME (2018) Prostaglandin D2\/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets. J Neuroinflam 15(1):272. https:\/\/doi.org\/10.1186\/s12974-018-1305-3","journal-title":"J Neuroinflam"},{"issue":"2","key":"764_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","volume":"3","author":"E Croisier","year":"2005","unstructured":"Croisier E, Moran LB, Dexter DT, Pearce RK, Graeber MB (2005) Microglial inflammation in the parkinsoniansubstantianigra: relationship to alpha-synuclein deposition. J Neuroinflam 3(2):14","journal-title":"J Neuroinflam"},{"issue":"8","key":"764_CR26","first-page":"165","volume":"8","author":"A Cz\u0142onkowska","year":"2002","unstructured":"Cz\u0142onkowska A, Kurkowska-Jastrzebska I, Cz\u0142onkowski A, Peter D, Stefano GB (2002) Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide. Med Sci Monitor Internat Med J Experiment Clin Res 8(8):165\u2013177","journal-title":"Med Sci Monitor Internat Med J Experiment Clin Res"},{"issue":"6","key":"764_CR27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/jphp.12203","volume":"66","author":"A Dannoura","year":"2014","unstructured":"Dannoura A, Giraldo A, Pereira I, Gibbins JM, Dash PR, Bicknell KA, Brooks G (2014) Ibuprofen inhibits migration and proliferation of human coronary artery smooth muscle cells by inducing a differentiated phenotype: role of peroxisome proliferator-activated receptor \u03b3. J Pharm Pharmacol 66(6):779\u2013792. https:\/\/doi.org\/10.1111\/jphp.12203","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"764_CR28","first-page":"649","volume":"20","author":"B Desvergne","year":"1999","unstructured":"Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20(5):649\u2013688","journal-title":"Endocr Rev"},{"issue":"4","key":"764_CR29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3(4):461\u2013491","journal-title":"J Parkinsons Dis"},{"issue":"8","key":"764_CR30","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.bbadis.2013.03.019","volume":"1832","author":"A Dixit","year":"2013","unstructured":"Dixit A, Srivastava G, Verma D, Mishra M, Singh PK, Prakash O, Singh MP (2013) Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease. Biochim Biophys Acta 1832(8):1227\u20131240","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"764_CR31","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1523\/JNEUROSCI.19-02-00562.1999","volume":"19","author":"R Dringen","year":"1999","unstructured":"Dringen R, Pfeiffer B, Hamprecht B (1999) Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci Off Soc Neurosci 19(2):562\u2013569. https:\/\/doi.org\/10.1523\/JNEUROSCI.19-02-00562.1999","journal-title":"J Neurosci Off Soc Neurosci"},{"issue":"2","key":"764_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neulet.2004.10.087","volume":"375","author":"NS Elsisi","year":"2005","unstructured":"Elsisi NS, Darling-Reed S, Lee EY, Oriaku ET, Soliman KF (2005) Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia. Neurosci Lett 375(2):91\u201396. https:\/\/doi.org\/10.1016\/j.neulet.2004.10.087","journal-title":"Neurosci Lett"},{"issue":"5","key":"764_CR34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","volume":"135","author":"JV Esplugues","year":"2002","unstructured":"Esplugues JV (2002) NO as a signalling molecule in the nervous system. Br J Pharmacol 135(5):1079\u20131095","journal-title":"Br J Pharmacol"},{"issue":"2","key":"764_CR35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.expneurol.2007.02.008","volume":"205","author":"E Esposito","year":"2007","unstructured":"Esposito E, Di Matteo V, Benigno A, Pierucci M, Crescimanno G, Di Giovanni G (2007) Non-steroidal anti-inflammatory drugs in Parkinson's disease. Exp Neurol 205(2):295\u2013312","journal-title":"Exp Neurol"},{"issue":"3","key":"764_CR36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1471-4159.2006.04371.x","volume":"101","author":"AA Farooqui","year":"2007","unstructured":"Farooqui AA, Horrocks LA, Farooqui T (2007) Modulation of inflammation in brain: a matter of fat. J Neurochem 101(3):577\u2013599","journal-title":"J Neurochem"},{"issue":"7","key":"764_CR37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33(7):829\u2013837","journal-title":"Eur Heart J"},{"issue":"3","key":"764_CR38","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s12035-013-8620-6","volume":"49","author":"R Fu","year":"2014","unstructured":"Fu R, Shen Q, Xu P, Luo JJ, Tang Y (2014) Phagocytosis of microglia in the central nervous system diseases. Mol Neurobiol 49(3):1422\u20131434","journal-title":"Mol Neurobiol"},{"issue":"12","key":"764_CR39","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","volume":"74","author":"JJ Gagne","year":"2010","unstructured":"Gagne JJ, Power MC (2010) Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 74(12):995\u20131002. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d5a4a3","journal-title":"Neurology"},{"issue":"10","key":"764_CR40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","volume":"76","author":"X Gao","year":"2011","unstructured":"Gao X, Chen H, Schwarzschild MA, Ascherio A (2011) Use of ibuprofen and risk of Parkinson disease. Neurology 76(10):863\u2013869","journal-title":"Neurology"},{"issue":"2","key":"764_CR41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40478-014-0176-9","volume":"13","author":"R Gir\u00e1ldez-P\u00e9rez","year":"2014","unstructured":"Gir\u00e1ldez-P\u00e9rez R, Antol\u00edn-Vallesp\u00edn M, Mu\u00f1oz M, S\u00e1nchez-Capelo A (2014) Models of \u03b1-synuclein aggregation in Parkinson\u2019s disease. Acta Neuropathol Commun 13(2):176","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"764_CR42","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140(6):918\u2013934","journal-title":"Cell"},{"issue":"23","key":"764_CR43","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1016\/j.febslet.2011.08.033","volume":"585","author":"MB Graeber","year":"2011","unstructured":"Graeber MB, Li W, Rodriguez ML (2011) Role of microglia in CNS inflammation. FEBSLett 585(23):3798\u20133805","journal-title":"FEBSLett"},{"key":"764_CR44","first-page":"151097","volume":"9","author":"MR Griffiths","year":"2010","unstructured":"Griffiths MR, Gasque P, Neal JW (2010) The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review. Int J Inflam 9:151097","journal-title":"Int J Inflam"},{"issue":"3","key":"764_CR45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2004.6.3\/ahartmann","volume":"6","author":"A Hartmann","year":"2004","unstructured":"Hartmann A (2004) Postmortem studies in Parkinson\u2019s disease. Dialogues ClinNeurosci 6(3):281\u2013293","journal-title":"Dialogues ClinNeurosci"},{"issue":"2","key":"764_CR46","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.64020919.x","volume":"64","author":"TG Hastings","year":"1995","unstructured":"Hastings TG (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem 64(2):919\u2013924. https:\/\/doi.org\/10.1046\/j.1471-4159.1995.64020919.x","journal-title":"J Neurochem"},{"issue":"2","key":"764_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41577-018-0112-5","volume":"19","author":"MT Heneka","year":"2019","unstructured":"Heneka MT (2019) Microglia take centre stage in neurodegenerative disease. Nat Rev Immunol 19(2):79\u201380. https:\/\/doi.org\/10.1038\/s41577-018-0112-5","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"764_CR48","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","volume":"1771","author":"MT Heneka","year":"2007","unstructured":"Heneka MT, Landreth GE (2007) PPARs in the brain. Biochim Biophys Acta 1771(8):1031\u20131045","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"764_CR49","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/brain\/awh452","volume":"128","author":"MT Heneka","year":"2005","unstructured":"Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, O'Banion K, Klockgether T, Van Leuven F, Landreth GE (2005) Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1\u201342 levels in APPV717I transgenic mice. Brain j neurol 128(6):1442\u20131453. https:\/\/doi.org\/10.1093\/brain\/awh452","journal-title":"Brain j neurol"},{"issue":"8","key":"764_CR50","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nrl.2015.06.011","volume":"32","author":"D Hernandez-Baltazar","year":"2017","unstructured":"Hernandez-Baltazar D, Zavala-Flores LM, Villanueva-Olivo A (2017) The 6-hydroxydopamine model and parkinsonian pathophysiology: novel findings in an older model. Neurolog\u00eda 32(8):533\u2013539","journal-title":"Neurolog\u00eda"},{"issue":"2","key":"764_CR51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00210-011-0660-8","volume":"384","author":"YC Hsieh","year":"2011","unstructured":"Hsieh YC, Mounsey RB, Teismann P (2011) MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress. NaunynSchmiedebergs Arch Pharmacol 384(2):157\u2013167","journal-title":"NaunynSchmiedebergs Arch Pharmacol"},{"issue":"4","key":"764_CR52","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0306-4522(85)90095-8","volume":"16","author":"O Isacson","year":"1985","unstructured":"Isacson O, Brundin P, Gage FH, Bj\u00f6rklund A (1985) Neural grafting in a rat model of Huntington\u2019s disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting. Neuroscience 16(4):799\u2013817. https:\/\/doi.org\/10.1016\/0306-4522(85)90095-8","journal-title":"Neuroscience"},{"key":"764_CR53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/9781118743614.ch4","volume-title":"Ibuprofen: Discovery","author":"F Jamali","year":"2015","unstructured":"Jamali F, Brocks DR (2015) The Pharmacokinetics of Ibuprofen in Humans and Animals. In: Rainsford KD (ed) Ibuprofen: Discovery. Development and Therapeutics, First Edition, pp 81\u2013130"},{"issue":"12","key":"764_CR54","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/s0006-2952(01)00822-x","volume":"62","author":"MS Jaradat","year":"2001","unstructured":"Jaradat MS, Wongsud B, Phornchirasilp S, Rangwala SM, Shams G, Sutton M, Romstedt KJ, Noonan DJ, Feller DR (2001) Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin. Biochem Pharmacol 62(12):1587\u20131595. https:\/\/doi.org\/10.1016\/s0006-2952(01)00822-x","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"764_CR55","first-page":"823","volume":"42","author":"HK Jeong","year":"2010","unstructured":"Jeong HK, Jou I, Joe EH (2010) Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantianigra. ExpMol Med 42(12):823\u2013832","journal-title":"ExpMol Med"},{"issue":"3","key":"764_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/jnr.24185","volume":"96","author":"N Joshi","year":"2018","unstructured":"Joshi N, Singh S (2018) Updates on immunity and inflammation in Parkinson disease pathology. J Neurosci Res 96(3):379\u2013390. https:\/\/doi.org\/10.1002\/jnr.24185","journal-title":"J Neurosci Res"},{"key":"764_CR57","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2741\/2802","volume":"13","author":"R Kapadia","year":"2008","unstructured":"Kapadia R, Yi JH, Vemuganti R (2008) Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci J Virt Lib 13:1813\u20131826. https:\/\/doi.org\/10.2741\/2802","journal-title":"Front Biosci J Virt Lib"},{"key":"764_CR58","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1073\/pnas.93.6.2317","volume":"93","author":"WE Kaufmann","year":"1996","unstructured":"Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P (1996) COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci U S A 93:2317\u20132321","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"764_CR59","first-page":"333","volume":"38","author":"YS Kim","year":"2006","unstructured":"Kim YS, Joh TH (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease. ExpMol Med 38(4):333\u2013347","journal-title":"ExpMol Med"},{"issue":"3","key":"764_CR60","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/ars.2008.2234","volume":"11","author":"AB Knott","year":"2009","unstructured":"Knott AB, Bossy-Wetzel E (2009) Nitric oxide in health and disease of the nervous system. Antioxid Redox Signal 11(3):541\u2013554","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"764_CR61","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.3390\/ijerph8072980","volume":"8","author":"AD Kraft","year":"2011","unstructured":"Kraft AD, Harry GJ (2011) Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. Int J Environ Res Public Health 8(7):2980\u20133018","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"764_CR62","first-page":"a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring HarbPerspect Biol 1(6):a001651","journal-title":"Cold Spring HarbPerspect Biol"},{"issue":"9","key":"764_CR63","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3858\/emm.2009.41.9.069","volume":"41","author":"JA Lee","year":"2009","unstructured":"Lee JA, Song HY, Ju SM, Lee SJ, Kwon HJ, Eum WS, Jang SH, Choi SY, Park JS (2009) Differential regulation of inducible nitric oxide synthase and cyclooxygenase-2 expression by superoxide dismutase in lipopolysaccharide stimulated RAW 264.7 cells. Exp Mol Med 41(9):629\u2013637","journal-title":"Exp Mol Med"},{"key":"764_CR64","doi-asserted-by":"crossref","first-page":"5012129","DOI":"10.1155\/2017\/5012129","volume":"2017","author":"F Longhena","year":"2017","unstructured":"Longhena F, Faustini G, Missale C, Pizzi M, Spano P, Bellucci A (2017) The contribution of \u03b1-Synuclein spreading to Parkinson's DiseaseSynaptopathy. Neural Plast 2017:5012129","journal-title":"Neural Plast"},{"issue":"4","key":"764_CR65","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","volume":"7","author":"ME Lull","year":"2010","unstructured":"Lull ME, Block ML (2010) Microglial activation and chronic neurodegeneration. Neurotherapeutics 7(4):354\u2013365","journal-title":"Neurotherapeutics"},{"issue":"1","key":"764_CR66","first-page":"23","volume":"17","author":"S Mandal","year":"2018","unstructured":"Mandal S, Mandal SD, Chuttani K, Sawant KK, Subudhi BB (2018) Preclinical study of ibuprofen loaded transnasal mucoadhesive microemulsion for neuroprotective effect in MPTP mice model. Iran J Pharma Res IJPR 17(1):23\u201338","journal-title":"Iran J Pharma Res IJPR"},{"issue":"Suppl 1","key":"764_CR67","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","volume":"10","author":"PL McGeer","year":"2004","unstructured":"McGeer PL, McGeer EG (2004) Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 10(Suppl 1):S3\u20137","journal-title":"Parkinsonism Relat Disord"},{"key":"764_CR68","first-page":"138","volume":"3","author":"E McGeer","year":"2001","unstructured":"McGeer E, Yasojima K, McGeer LP (2001) Inflammation in the pathogenesis of Parkinson\u2019s disease. BCMJ 3:138\u2013141","journal-title":"BCMJ"},{"issue":"2","key":"764_CR69","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/s0378-4347(00)83780-9","volume":"532","author":"S Menzel-Soglowek","year":"1990","unstructured":"Menzel-Soglowek S, Geisslinger G, Brune K (1990) Stereoselective high-performance liquid chromatographic determination of ketoprofen, ibuprofen and fenoprofen in plasma using a chiral alpha 1-acid glycoprotein column. J Chromatogr 532(2):295\u2013303. https:\/\/doi.org\/10.1016\/s0378-4347(00)83780-9","journal-title":"J Chromatogr"},{"issue":"9","key":"764_CR70","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","volume":"63","author":"L Minghetti","year":"2004","unstructured":"Minghetti L (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63(9):901\u2013910","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"764_CR71","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/(SICI)1098-1136(199702)19:2<152::AID-GLIA6>3.0.CO;2-2","volume":"19","author":"L Minghetti","year":"1997","unstructured":"Minghetti L, Nicolini A, Polazzi E, Cr\u00e9minon C, Maclouf J, Levi G (1997) Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia 19(2):152\u2013160","journal-title":"Glia"},{"issue":"6","key":"764_CR72","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3390\/ph3061812","volume":"3","author":"AH Moore","year":"2010","unstructured":"Moore AH, Bigbee MJ, Boynton GE, Wakeham CM, Rosenheim HM, Staral CJ, Morrissey JL, Hund AK (2010) Non-steroidal anti-inflammatory drugs in Alzheimer\u2019s Disease and Parkinson's Disease: reconsidering the role of neuroinflammation. Pharmaceuticals (Basel) 3(6):1812\u20131841","journal-title":"Pharmaceuticals (Basel)"},{"key":"764_CR73","first-page":"952375","volume":"2013","author":"SV More","year":"2013","unstructured":"More SV, Kumar H, Kim IS, Song SY, Choi DK (2013) Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. Med Inflamm 2013:952375","journal-title":"Med Inflamm"},{"issue":"5","key":"764_CR74","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","volume":"6","author":"RL Mosley","year":"2006","unstructured":"Mosley RL, Benner EJ, Kadiu I, Thomas M, Boska MD, Hasan K, Laurie C, Gendelman HE (2006) Neuroinflammation, oxidative stress and the pathogenesis of Parkinson\u2019s disease. Clin Neuro sci Res 6(5):261\u2013281","journal-title":"Clin Neuro sci Res"},{"issue":"3","key":"764_CR75","first-page":"801","volume":"30","author":"S Naeem","year":"2017","unstructured":"Naeem S, Ikram R, Khan SS, Rao SS (2017) NSAIDs ameliorate cognitive and motor impairment in a model of parkinsonism induced by chlorpromazine. Pakistan J Pharma Sci 30(3):801\u2013808","journal-title":"Pakistan J Pharma Sci"},{"issue":"4","key":"764_CR76","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1021\/tx010004x","volume":"14","author":"D Nikolic","year":"2001","unstructured":"Nikolic D, van Breemen RB (2001) DNA oxidation induced by cyclooxygenase-2. Chem Res Toxicol 14(4):351\u2013354. https:\/\/doi.org\/10.1021\/tx010004x","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"764_CR77","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol 57(2):168\u2013175. https:\/\/doi.org\/10.1002\/ana.20338","journal-title":"Ann Neurol"},{"issue":"3","key":"764_CR78","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/imm.12163","volume":"141","author":"L Peferoen","year":"2014","unstructured":"Peferoen L, Kipp M, van der Valk P, van Noort JM, Amor S (2014) Oligodendrocyte-microglia cross-talk in the central nervous system. Immunology 141(3):302\u2013313","journal-title":"Immunology"},{"issue":"9","key":"764_CR79","first-page":"a009373","volume":"2","author":"VH Perry","year":"2012","unstructured":"Perry VH (2012) Innate inflammation in Parkinson\u2019s disease. Cold Spring HarbPerspect Med 2(9):a009373","journal-title":"Cold Spring HarbPerspect Med"},{"issue":"5","key":"764_CR80","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","volume":"35","author":"VH Perry","year":"2013","unstructured":"Perry VH, Teeling J (2013) Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol 35(5):601\u2013612","journal-title":"Semin Immunopathol"},{"key":"764_CR81","doi-asserted-by":"publisher","first-page":"5071786","DOI":"10.1155\/2017\/5071786","volume":"2017","author":"FA Radtke","year":"2017","unstructured":"Radtke FA, Chapman G, Hall J, Syed YA (2017) Modulating neuroinflammation to treat neuropsychiatric disorders. Biomed Res Int 2017:5071786. https:\/\/doi.org\/10.1155\/2017\/5071786","journal-title":"Biomed Res Int"},{"key":"764_CR82","volume-title":"Ibuprofen: Pharmacology","author":"KD Rainsford","year":"2012","unstructured":"Rainsford KD (2012) Ibuprofen: Pharmacology. Therapeutics and Side Effects, Springer, Heidelberg New York Dordrecht London"},{"issue":"5","key":"764_CR83","doi-asserted-by":"publisher","first-page":"477","DOI":"10.22038\/IJBMS.2019.34011.8091","volume":"22","author":"E Ramazani","year":"2019","unstructured":"Ramazani E, Tayarani-Najaran Z, Fereidoni M (2019) Celecoxib, indomethacin, and ibuprofen prevent 6-hydroxydopamine-induced PC12 cell death through the inhibition of NF\u03baB and SAPK\/JNK pathways. Iran J Basic Med Sci 22(5):477\u2013484. https:\/\/doi.org\/10.22038\/IJBMS.2019.34011.8091","journal-title":"Iran J Basic Med Sci"},{"issue":"8","key":"764_CR84","first-page":"159","volume":"18","author":"A Recasens","year":"2014","unstructured":"Recasens A, Dehay B (2014) Alpha-synuclein spreading in Parkinson's disease. Front Neuroanat 18(8):159","journal-title":"Front Neuroanat"},{"issue":"37","key":"764_CR85","doi-asserted-by":"publisher","first-page":"e12172","DOI":"10.1097\/MD.0000000000012172","volume":"97","author":"L Ren","year":"2018","unstructured":"Ren L, Yi J, Yang J, Li P, Cheng X, Mao P (2018) Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease: A dose-response meta-analysis. Medicine 97(37):e12172. https:\/\/doi.org\/10.1097\/MD.0000000000012172","journal-title":"Medicine"},{"issue":"5","key":"764_CR86","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti E, FitzGerald GA (2011) Prostaglandins and inflammation. Arterioscler Throm Vasc Biol 31(5):986\u20131000","journal-title":"Arterioscler Throm Vasc Biol"},{"issue":"4","key":"764_CR87","first-page":"942","volume":"17","author":"RB Rock","year":"2004","unstructured":"Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, Peterson PK (2004) Role of microglia in central nervous system infections. ClinMicrobiol Rev 17(4):942\u2013964","journal-title":"ClinMicrobiol Rev"},{"issue":"5\u20136","key":"764_CR88","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1089\/ars.2006.8.929","volume":"8","author":"RN Saha","year":"2006","unstructured":"Saha RN, Pahan K (2006) Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 8(5\u20136):929\u2013947","journal-title":"Antioxid Redox Signal"},{"issue":"15","key":"764_CR89","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1073\/pnas.90.15.7240","volume":"90","author":"D Salvemini","year":"1993","unstructured":"Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90(15):7240\u20137244","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"764_CR90","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-2094-1-6","volume":"1","author":"R S\u00e1nchez-Pernaute","year":"2004","unstructured":"S\u00e1nchez-Pernaute R, Ferree A, Cooper O, Yu M, Brownell AL, Isacson O (2004) Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. J Neuroinflam 1(1):6. https:\/\/doi.org\/10.1186\/1742-2094-1-6","journal-title":"J Neuroinflam"},{"issue":"6","key":"764_CR91","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1023\/a:1007048903862","volume":"28","author":"J Schiefer","year":"1999","unstructured":"Schiefer J, Kampe K, Dodt HU, Zieglg\u00e4nsberger W, Kreutzberg GW (1999) Microglial motility in the rat facial nucleus following peripheral axotomy. J Neurocytol 28(6):439\u2013453. https:\/\/doi.org\/10.1023\/a:1007048903862","journal-title":"J Neurocytol"},{"issue":"3","key":"764_CR92","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"DL Simmons","year":"2004","unstructured":"Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56(3):387\u2013437","journal-title":"Pharmacol Rev"},{"issue":"11","key":"764_CR93","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3109\/00207454.2011.598981","volume":"121","author":"S Singh","year":"2011","unstructured":"Singh S, Swarnkar S, Goswami P, Nath C (2011) Astrocytes and microglia: responses to neuropathological conditions. Internat J Neurosci 121(11):589\u2013597. https:\/\/doi.org\/10.3109\/00207454.2011.598981","journal-title":"Internat J Neurosci"},{"key":"764_CR94","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neurobiolaging.2010.02.018","volume":"33","author":"AK Singh","year":"2012","unstructured":"Singh AK, Tiwari MN, Upadhyay G, Patel DK, Singh D, Prakash O, Singh MP (2012) Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol Aging 33:404\u2013415","journal-title":"Neurobiol Aging"},{"key":"764_CR95","first-page":"6849","volume":"53","author":"A Singh","year":"2016","unstructured":"Singh A, Tripathi P, Prakash O, Singh MP (2016) Ibuprofen abates cypermethrin-induced expression of pro-inflammatory mediators and mitogen-activated protein kinases and averts the nigrostriatal dopaminergic neurodegeneration. MolNeurobiol 53:6849\u20136858","journal-title":"MolNeurobiol"},{"issue":"10","key":"764_CR96","first-page":"8071","volume":"54","author":"M Sochocka","year":"2017","unstructured":"Sochocka M, Diniz BS, Leszek J (2017) Inflammatory response in the CNS: friend or Foe? MolNeurobiol 54(10):8071\u20138089","journal-title":"MolNeurobiol"},{"issue":"8","key":"764_CR97","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.freeradbiomed.2012.02.005","volume":"52","author":"G Srivastava","year":"2012","unstructured":"Srivastava G, Dixit A, Yadav S, Patel DK, Prakash O, Singh MP (2012) Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse. Free RadicBiol Med 52(8):1294\u20131306","journal-title":"Free RadicBiol Med"},{"issue":"2","key":"764_CR98","first-page":"a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson's disease. Cold Spring HarbPerspect Med 2(2):a009399","journal-title":"Cold Spring HarbPerspect Med"},{"issue":"1\u20132","key":"764_CR99","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0169-328x(97)00168-x","volume":"50","author":"NC Stratman","year":"1997","unstructured":"Stratman NC, Carter DB, Sethy VH (1997) Ibuprofen: effect on inducible nitric oxide synthase. Brain Res Mol Brain Res 50(1\u20132):107\u2013112. https:\/\/doi.org\/10.1016\/s0169-328x(97)00168-x","journal-title":"Brain Res Mol Brain Res"},{"key":"764_CR100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/med.1006","volume":"21","author":"DS Straus","year":"2001","unstructured":"Straus DS, Glass CK (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21:185\u2013210","journal-title":"Med Res Rev"},{"issue":"11","key":"764_CR101","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.neurobiolaging.2007.04.006","volume":"29","author":"X Su","year":"2008","unstructured":"Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ (2008) Synuclein activates microglia in a model of Parkinson's disease. Neurobiol Aging 29(11):1690\u20131701","journal-title":"Neurobiol Aging"},{"issue":"11","key":"764_CR102","doi-asserted-by":"publisher","first-page":"10444","DOI":"10.1074\/jbc.M413863200","volume":"280","author":"H Takeuchi","year":"2005","unstructured":"Takeuchi H, Mizuno T, Zhang G, Wang J, Kawanokuchi J, Kuno R, Suzumura A (2005) Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J Biol Chem 280(11):10444\u201310454. https:\/\/doi.org\/10.1074\/jbc.M413863200","journal-title":"J Biol Chem"},{"issue":"3","key":"764_CR103","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37(3):510\u2013518","journal-title":"Neurobiol Dis"},{"issue":"6","key":"764_CR104","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/biof.1035","volume":"38","author":"P Teismann","year":"2012","unstructured":"Teismann P (2012) COX-2 in the neurodegenerative process of Parkinson\u2019s disease. BioFactors (Oxford, England) 38(6):395\u2013397. https:\/\/doi.org\/10.1002\/biof.1035","journal-title":"BioFactors (Oxford, England)"},{"issue":"12","key":"764_CR105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","volume":"67","author":"S Theodore","year":"2008","unstructured":"Theodore S, Cao S, McLean PJ, Standaert DG (2008) Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol 67(12):1149\u20131158","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"764_CR106","first-page":"2333","volume":"55","author":"P Tripathi","year":"2018","unstructured":"Tripathi P, Singh A, Bala L, Patel DK, Singh MP (2018) Ibuprofen protects from cypermethrin-induced changes in the striatal dendritic length and Spine Density. MolNeurobiol MolNeurobiol 55(3):2333\u20132339","journal-title":"MolNeurobiol MolNeurobiol"},{"key":"764_CR107","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s11064-008-9863-x","volume":"34","author":"T Tsuji","year":"2009","unstructured":"Tsuji T, Asanuma M, Miyazaki I, Miyoshi K, Ogawa N (2009) Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen. Neurochem Res 34:764\u2013774","journal-title":"Neurochem Res"},{"key":"764_CR108","first-page":"487","volume":"18","author":"KU Tufekci","year":"2011","unstructured":"Tufekci KU, Genc S, Genc K (2011) The endotoxin-induced neuroinflammation model of Parkinson\u2019s disease. Parkinsons Dis 18:487\u2013450","journal-title":"Parkinsons Dis"},{"key":"764_CR109","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1155\/S1110724304402034","volume":"4","author":"N Tuteja","year":"2004","unstructured":"Tuteja N, Chandra M, Tuteja R, Misra MK (2004) Nitric oxide as a unique bioactive signaling messenger in physiology and pathophysiology. J Biomed Biotechnol 4:227\u2013237","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"764_CR110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","volume":"7","author":"B Uttara","year":"2009","unstructured":"Uttara B, Singh AV, Zamboni P, Mahajan RT (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7(1):65\u201374","journal-title":"Curr Neuropharmacol"},{"issue":"1\u20133","key":"764_CR111","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejphar.2004.06.017","volume":"496","author":"P Van Antwerpen","year":"2004","unstructured":"Van Antwerpen P, N\u00e8ve J (2004) In vitro comparative assessment of the scavenging activity against three reactive oxygen species of non-steroidal anti-inflammatory drugs from the oxicam and sulfoanilide families. Eur J Pharmacol 496(1\u20133):55\u201361. https:\/\/doi.org\/10.1016\/j.ejphar.2004.06.017","journal-title":"Eur J Pharmacol"},{"key":"764_CR112","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-2094-3-6","volume":"3","author":"R Vijitruth","year":"2006","unstructured":"Vijitruth R, Liu M, Choi DY, Nguyen XV, Hunter RL, Bing G (2006) Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson\u2019s disease. J Neuroinflam 3:6. https:\/\/doi.org\/10.1186\/1742-2094-3-6","journal-title":"J Neuroinflam"},{"issue":"3","key":"764_CR113","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/s0306-4522(97)00424-7","volume":"83","author":"BT Volpe","year":"1998","unstructured":"Volpe BT, Wildmann J, Altar CA (1998) Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions. Neuroscience 83(3):741\u2013748. https:\/\/doi.org\/10.1016\/s0306-4522(97)00424-7","journal-title":"Neuroscience"},{"issue":"4","key":"764_CR114","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"12","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegen 12(4):19","journal-title":"Transl Neurodegen"},{"issue":"3","key":"764_CR115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-3-30","volume":"9","author":"BL Wilkinson","year":"2006","unstructured":"Wilkinson BL, Landreth GE (2006) The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease. J Neuroinflam 9(3):30","journal-title":"J Neuroinflam"},{"issue":"11","key":"764_CR116","doi-asserted-by":"crossref","first-page":"E2394","DOI":"10.3390\/ijms18112394","volume":"18","author":"A Wnuk","year":"2017","unstructured":"Wnuk A, Kajta M (2017) Steroid and xenobiotic receptor signalling in apoptosis and autophagy of the nervous system. Int J Mol Sci 18(11):E2394","journal-title":"Int J Mol Sci"},{"key":"764_CR117","first-page":"417646","volume":"2","author":"KK Wu","year":"2010","unstructured":"Wu KK (2010) peroxisome proliferator-activated receptors protect against apoptosis via 14-3-3. PPAR Res 2:417646","journal-title":"PPAR Res"},{"issue":"2","key":"764_CR118","first-page":"495","volume":"46","author":"S Yadav","year":"2012","unstructured":"Yadav S, Dixit A, Agrawal S, Singh A, Srivastava G, Singh AK, Srivastava PK, Prakash O, Singh MP (2012) Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis. MolNeurobiol 46(2):495\u2013512","journal-title":"MolNeurobiol"},{"issue":"5","key":"764_CR119","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3892\/mmr.2014.2563","volume":"10","author":"J Yan","year":"2014","unstructured":"Yan J, Fu Q, Cheng L, Zhai M, Wu W, Huang L, Du G (2014) Inflammatory response in Parkinson\u2019s disease (Review). Mol Med Rep 10(5):2223\u20132233","journal-title":"Mol Med Rep"},{"issue":"7","key":"764_CR120","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/1389450111314070003","volume":"14","author":"HM Yonutas","year":"2013","unstructured":"Yonutas HM, Sullivan PG (2013) Targeting PPAR isoforms following CNS injury. Curr Drug Targets 14(7):733\u2013742. https:\/\/doi.org\/10.2174\/1389450111314070003","journal-title":"Curr Drug Targets"},{"issue":"4","key":"764_CR121","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12640-014-9467-y","volume":"26","author":"T Zaminelli","year":"2014","unstructured":"Zaminelli T, Gradowski RW, Bassani TB, Barbiero JK, Santiago RM, Maria-Ferreira D, Baggio CH, Vital MA (2014) Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson\u2019s disease. Neurotox Res 26(4):351\u2013362","journal-title":"Neurotox Res"},{"key":"764_CR122","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1742-2094-8-129","volume":"8","author":"WM Zawada","year":"2011","unstructured":"Zawada WM, Banninger GP, Thornton J, Marriott B, Cantu D, Rachubinski AL, Das M, Griffin WS, Jones SM (2011) Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave. Cascade J Neuroinflam 8:129","journal-title":"Cascade J Neuroinflam"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00764-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-020-00764-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00764-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T07:09:04Z","timestamp":1669187344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-020-00764-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["764"],"URL":"https:\/\/doi.org\/10.1007\/s10787-020-00764-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}}]}}